Trial Profile
A Randomized, Double-blind, Multicenter, Active-controlled Phase III Study to Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Levodropropizine (Primary) ; Levodropropizine
- Indications Bronchitis; Cough
- Focus Therapeutic Use
- Sponsors Hyundai Pharmaceutical
- 19 Nov 2018 Status changed from recruiting to completed.
- 30 Mar 2018 Status changed from planning to recruiting.
- 09 Mar 2016 New trial record